Jun Toda1, Michiko Ichii1, Hideaki Saito1, Yuichi Kitai2, Ryuta Muromoto2, Junichi Kashiwakura2, Kodai Saitoh2, Tadashi Matsuda2, Kenji Oritani3, Hirohiko Shibayama1, Yuzuru Kanakura1 (1.Hematology and Oncology, Osaka Univ., Osaka, Japan, 2.Immunology, Pharmaceutical Sciences, Hokkaido Univ., Sapporo, Japan, 3.Hematology, International University of Health and Welfare, Chiba, Japan)
Session information
Oral Session
Oral Session 2-11C CML: Basic (1)
Sat. Oct 12, 2019 2:50 PM - 3:50 PM No.11 (Tokyo International Forum, 5F G502)
Chair: Yosuke Minami (Department of Hematology, National Cancer Center Hospital East)
Kenta Moriyama, Toshiyuki Hori (Grad. Sch. Life Sci., Ritsumeikan Univ.)
Daisuke Koyama1, Jiro Kikuchi1, Yoshiaki Kuroda1, Masatsugu Ohta2, Yusuke Furukawa1 (1.Division of Stem Cell Regulation, Jichi Medical University, Tochigi, Japan, 2.Department of Hematology, FMU, Aizu Medical Center, Aizuwakamatsu, Japan)
Mariko Morii1, Sho Kubota1, Takako Yokomizo1, Masayoshi Tasaki2, Kimi Araki3,4, Goro Sashida1 (1.Laboratory of Transcriptional Regulation in Leukemogenesis, IRCMS, Kumamoto University, 2.Department of Morphological and Physiological Sciences, Kumamoto University, 3.Division of Developmental Genetics, IRDA, Kumamoto University, 4.Center for Metabolic Regulation of Healthy Aging, Kumamoto University)
Noorulain Fareed (Hematology, CHK LAB Civil Hospital Karachi, Karachi, Sindh, Islamic Republic of Pakistan)
Lobna Alkebsi, Xintao Wang, Hiroshi Ohkawara, Masahiko Fukatsu, Takayuki Ikezoe (Department of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan)